Ascendis Pharma Reports Fourth Quarter and Full Year 2024 Financial Results
Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million - Following pre-NDA meeting with FDA, on track to submit TransCon CNP ...
The Economic Times on MSN6h
Aviva's India arm hit with $7.5 million fine for fake invoice scheme, order shows
Indian authorities have ordered British insurer Aviva's local unit to pay $7.5 million in back taxes and penalties after an ...
Hosted on MSN4h
LVMH’s New Push: World’s Most Powerful Luxury Group Is Coming for Sports
LVMH is making long-term deals—and they’re not done. The post LVMH’s New Push: World’s Most Powerful Luxury Group Is Coming ...
The New York Times19h
World News
At the Munich Security Conference, Olaf Scholz accused the U.S. vice president of unacceptable interference in Germany’s coming elections. By Jim Tankersley and Andrew E. Kramer After years of ...
The New York Times12h
New York Times - Top Stories
An Unchecked Trump Rapidly Remakes U.S. Government and Foreign Policy President Trump’s swift moves underscore the confidence of an administration with a much firmer grip on the levers of ...